Study: Firms “underinvest” in long-term cancer research
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.
MIT collaborates on a smaller, lighter delivery system for proton-beam radiotherapy.
Senior biology and chemistry major Daniel Zhang helps build noninvasive cancer diagnostic tools.
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
Cancer biologist and Koch Institute director recognized with MIT faculty’s top honor.
Bhatia is recognized for her work in tissue engineering, disease detection, and advocacy for women in STEM.
Model from MIT's Computer Science and Artificial Intelligence Laboratory aims to automatically distinguish lymphoma subtypes.
Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy.
Stimulating both major branches of the immune system halts tumor growth more effectively.
Discovery could offer a new target for treatment of glioblastoma.
Acoustic device can rapidly isolate circulating tumor cells from patient blood samples.
MIT team finds mechanism by which exposure to vinyl chloride may produce cancerous mutations.
Graduate student Steven Keating takes a problem-solving approach to his brain cancer.